Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.
about
Evaluation of preoperative staging for esophageal squamous cell carcinomaRadiation therapy and esophageal cancerFalse-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal CancerPerformance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screeningThe role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancerBritish Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Imaging strategies in the management of oesophageal cancer: what's the role of MRI?Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results.An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue.18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.A case of advanced gastric cancer.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerNovel insights into esophageal diagnostic procedures.FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapyMetastases of esophageal carcinoma to skeletal muscle: single center experienceMolecular imaging: what can be used today.Role of positron emission tomography in the (re-)staging of oesophageal cancer.Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagusSynchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.Current treatment approach to locally advanced esophageal cancer: is resection mandatory?Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaPositron emission tomography imaging as a cancer biomarker.Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer.The role of positron emission tomography in esophageal cancer.The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis.Long-term survivorship of esophageal cancer patients treated with radical intentRadical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use?Staging esophageal cancer.Patients' perception of diagnostic tests in the preoperative assessment of esophageal cancer.A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer.Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.Preoperative T Staging of Potentially Resectable Esophageal Cancer: A Comparison between Free-Breathing Radial VIBE and Breath-Hold Cartesian VIBE, with Histopathological CorrelationRole of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.
P2860
Q26740186-D1DC94ED-C51A-4270-8885-E2B0C9C615C3Q27026922-9553486C-838D-4FF9-B08F-22386A37CCABQ33585101-5B13EEE6-F9B8-41AF-9E63-7860CB33EC61Q33599546-5E044EC9-DCDE-44FF-AFB3-5683407D7F61Q33902475-4879702F-CF53-49FB-B96A-FFC17E0AEADFQ34164634-5ED2C3F9-80EA-4DD4-83A0-9EE9EFF199A6Q34380645-139B1219-29C1-462E-A502-0158C4FEAB74Q34583617-72C85833-0494-44AF-B5EA-867D2762F5CEQ34954095-A056229A-8473-4AA8-8D6A-C35ADC028E2CQ35744447-451ED70D-7F48-487A-BD66-1A1643AF4413Q35830542-F36FFA8D-D4D2-497C-954F-D1A55AC67110Q36014962-F39C0D8A-7849-4C78-A675-DBEAB8D3D08DQ36032993-5DB1B807-F28D-4844-9302-094AF8BB1D95Q36146896-A5700756-9437-4C9C-B36B-9EF6D49D1DB3Q36240976-95610B86-5E82-4A58-B709-EB8F12637897Q36248229-20C1F214-F693-4A15-9677-7DC46A9E1BFEQ36345342-7479401A-914E-4B1E-9DCE-0D980085B434Q36510702-AFB7AF33-7B5F-48B1-8645-8EFE2E4533A8Q36623646-0D89F01D-56D2-46D1-9281-349FAA87A2BAQ36638081-6F0A8077-B86C-46DD-97A7-2627432826B6Q36677478-658E0ED7-7CF8-42F5-AD0D-E6DDC9CB020FQ36924872-58FDA5D2-7F36-4E4F-9703-F131128760FAQ36950458-545C00DC-C372-4A72-8B53-0F370AE63FB0Q36959768-C6DCF263-FE90-49A6-91F7-6297CF61861DQ37072481-0546850E-6DC3-483F-B3BC-E3EF8B407729Q37076617-2C5DD106-7481-476A-8988-300CE5CB302EQ37116282-B91359F4-EC91-4B13-BB19-985C9EF9776FQ37144262-7F76C10B-48DF-43B2-B8A7-C8F1D3CBF15EQ37270111-14A355A4-9057-4E8F-A0A3-3C374808C0A5Q37292830-EB60F06A-2C1C-4314-A369-639A7BA8AEA7Q37405552-ADD5C911-73D9-416B-ABCE-1A82DCB01C73Q37406693-326CAF84-8FB9-4882-ABF6-CE90BEFDE13DQ37440114-F9AA9C8E-C529-45A4-A328-8A92961A0233Q37492159-B5B8338D-CE81-4058-9543-A7E471A434B2Q37594603-BB84F82D-B50E-45EB-888B-9440A0FD1765Q37681293-A2A5B61F-6701-407B-A604-2468EBEEE43BQ37712152-C35BA8DE-CD96-44B3-88A5-4F773EFA826AQ37968594-4BFED80F-12D3-4DC4-8AB2-D1890602E49EQ38107133-33329514-5FF7-4B2C-BEDE-856EB3CC0147Q38340518-D652CDF1-BE80-4052-BB7A-D6EBBE5A42C1
P2860
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systematic review of the stagi ...... mography in esophageal cancer.
@ast
Systematic review of the stagi ...... mography in esophageal cancer.
@en
type
label
Systematic review of the stagi ...... mography in esophageal cancer.
@ast
Systematic review of the stagi ...... mography in esophageal cancer.
@en
prefLabel
Systematic review of the stagi ...... mography in esophageal cancer.
@ast
Systematic review of the stagi ...... mography in esophageal cancer.
@en
P2093
P356
P1476
Systematic review of the stagi ...... mography in esophageal cancer.
@en
P2093
H L van Westreenen
J J B van Lanschot
J Th M Plukker
M Westerterp
P M M Bossuyt
P304
P356
10.1200/JCO.2004.01.083
P407
P577
2004-09-01T00:00:00Z